The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Am J Psychiatry 163:2002-2004, November 2006
doi: 10.1176/appi.ajp.163.11.2002
© 2006 American Psychiatric Association
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Roberts, L. W.
* Articles by Hoop, J.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Roberts, L. W.
* Articles by Hoop, J.
Related Collections
* Informed Consent
* Other Ethics Issues
* Schizophrenia Spectrum Disorders
* Cognition

Brief Report

An Inverse Relationship Between Perceived Harm and Participation Willingness in Schizophrenia Research Protocols

Laura Weiss Roberts, M.D., Katherine Green Hammond, Ph.D., and Jinger Hoop, M.D., M.F.A.

OBJECTIVE: This study attempted to clarify how people with schizophrenia evaluate the potential harm associated with various research-related procedures and how these assessments relate to participation willingness. METHOD: The authors conducted a semistructured interview among participants with schizophrenia. RESULTS: Sixty participants with schizophrenia rated four procedures as harmful (e.g., symptom induction), five procedures as moderately harmful (e.g., being given a placebo), and six procedures as not harmful (e.g., undergoing a physical examination). Rated willingness to participate was inversely related to the participants’ perceptions of harmfulness for all procedures. CONCLUSIONS: In this study, people living with schizophrenia perceived different research procedures as posing different levels of possible harm. Potential harm appears to be an important consideration in protocol enrollment decisions. This work reaffirms the value of clarifying the strengths of seriously ill people who may choose to participate in research.




This article has been cited by other articles:


Home page
Schizophr BullHome page
R. P. McMahon, D. L. Kelly, D. L. Boggs, L. Li, Q. Hu, J. M. Davis, and W. T. Carpenter Jr.
Feasibility of Reducing the Duration of Placebo-Controlled Trials in Schizophrenia Research
Schizophr Bull, March 1, 2008; 34(2): 292 - 301.
[Abstract] [Full Text] [PDF]


Home page
Schizophr BullHome page
L. B. Dunn, D. S. Kim, I. E. Fellows, and B. W. Palmer
Worth the Risk? Relationship of Incentives to Risk and Benefit Perceptions and Willingness to Participate in Schizophrenia Research
Schizophr Bull, February 14, 2008; (2008) sbn003v1.
[Abstract] [Full Text] [PDF]


Home page
Psychiatr. Serv.Home page
L. W. Roberts, T. D. Warner, K. G. Hammond, and L. B. Dunn
Assessments by Patients With Schizophrenia and Psychiatrists of Relative Risk of Research Procedures
Psychiatr Serv, November 1, 2006; 57(11): 1629 - 1635.
[Abstract] [Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 2006 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org